Cite Filings / ORMP / 0001213900-23-044530

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

ORAMED PHARMACEUTICALS INC. Filed 2023-05-31 Acc 0001213900-23-044530

Documents 1

DEF 14A Proxy Statement , ea179423-def14a_oramed.htm

Around this filing

2024-06-20 DEF 14A Proxy Statement
2023-05-31 ARS Annual Report to Security Holders
2023-05-31 DEF 14A Proxy Statement
2023-05-31 4 President and CEO acquired 120,000 shares (grant or award)
2023-05-31 4 Chief Legal Officer acquired 20,500 shares (grant or award)
2023-05-31 4 Chief Scientific Officer acquired 53,500 shares (grant or award)
2022-06-02 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading ea179423-def14a_oramed.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…